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Compete or incomplete transformation?
Ecotoxicity of parant compounds and transformation products?
Background










































































































































































Tran et al., 
2009
Atenolol Sathyamoorthy et al., 2013
EE2 Khunjar et al., 2011
A variety of 
PPCPs
Kreuzinger et al., 2005;
Fernandez-Fontaina et al., 
2012; Rattier et al., 2004





































Parent compounds Transformation products
To test the hypothesis
 Pure culture study 
 Ammonia-Oxidizing Bacteria (AOB)
? Ammonia-Oxidizing Archaea (AOA)
 Inhibition study
 Removal in full-scale WWTPs









• Distribution and abundance
• Distinct physiological characteristics













Venlafaxine (VEN) Mianserin (MIA) Pheniramine (PHE) Ranitidine (RAN)
 Tested ammonia oxidizers:
AOA: Nitrososphaera gargensis
AOB: Nitrosomonas nitrosa strain Nm90, Nm95
7
MP biotransformation capability of AOA















































































 AOA, BT  AOA, dead ctrl
 Nm90, BT  Nm90, dead ctrl
 Nm95, BT  Nm95, dead ctrl
MIA












 AOA, BT  AOA, dead ctrl
 Nm90, BT  Nm90, dead ctrl
 Nm95, BT  Nm95, dead ctrl
RAN
Biotransformation rate constant 
(normalized to total protein)
Two MPs (MIA and RAN) were biotransformed by AOA
Relative removal



























































 One TP (m/z 279.1492) of MIA was determined to be α-oxo mianserin. 
 No N-oxidation (mianserin N-oxide) or N-demethylation (normianserin)
 No suspected RAN TP was detected, except RAN S-oxide
 Three RAN TPs from non target analysis
Transformation product (TP) identification
9
MIA RAN
(Men et al., 2016. ES&T)
α-oxo MIA
(TPs were semi-quantified according to peak areas)
R
RANMIA
Summary — Pure culture study
 N. gargensis (an AOA strain) can biotransform two out of the
ten tested MPs: mianserin (MIA) and ranitidine (RAN).
 α-oxo mianserin was the major MIA TP.
 Three TPs were identified for RAN from non-target analysis.




Parent compounds Transformation products
To test the hypothesis




Removal in full-scale WWTPs






















With inhibitor(AOB and/or AOA)
MPs TPs


























































Roles of AOA in MP biotransformation
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AOA: partial/none Cu chelator
Ginestet et al. 1998, 
Jantti et al. 2013
Octyne (OCT) 20 µM Caq
AOB: 100%
AOA: partial/none
Covalent binding to 
AMO Taylor et al., 2013


































ATU and OCT exhibited different inhibition on AOB
14






AOA: partial/none Cu chelator
Ginestet et al. 1998, 
Jantti et al. 2013
Octyne (OCT) 20 µM Caq
AOB: 100%
AOA: partial/none
Covalent binding to 
AMO Taylor et al., 2013
MP biotransformation NH4-N





































Strong sorption & 
fast abiotic removal
Total
55 20 4 79





































































































































































































































































































































































31 of the 55 MPs (56%) were inhibited by ATU and/or OCT.

















17 MPs with higher inhibition by ATU than OCT
16


















Removal (R) Rate constant (k),  h-1
Roles played by different NAS community members




Classification of members in a NAS community based on ATU sensitivity
Microorganisms with 
ATU-affected enzymes
Roles played by different NAS community members
This study: ATU does not specifically inhibit AOB, and other ATU-affected 






Refined Classification of members in a NAS community based on ATU sensitivity
AOB Other ATU-affected microbes ATU-unaffected microbes
Similar inhibition Higher inhibition by ATU No inhibition
Comparing inhibition effects of ATU and OCT
Contribution of the three microbial groups
19
Extent of inhibition (I) = , 










I : how much the inhibited member contribute to MP biotransformation
20
11 MPs with similar inhibition by ATU and OCT





































































































































Recovery of nitrification after 46h in OCT-treated samples
































































AOB played a major role in the biotransformation of 4 MPs
22
46h Inhibition ATU:OCT > 1.5 for 17 compounds
Number in parentheses (relative removal of the control at 46h unless specified) 
* indicates statistically significant difference with t-test and BH correction (FDR < 0.05)






















































































































































 AOB  other ATU-affected microorganisms  ATU-unaffected microorganisms
phenylurea pesticides thioethers
17 MPs with higher inhibition by ATU than OCT
No inhibition by the two AOB inhibitors for the following MPs: 
• Esters: hydrolysis
• Chloroacetanilides: 
• Sulfonamides: hydroxylation on aromatic ring
23
or
Oxanilic acid (OXA) Sulfonic acid (ESA)
No inhibition Inhibited by ATU
(~ 15%)
Sulfadiazine Sulfamethazine Sulfamethoxazole Sulfapyridine Sulfathiazole
Compound specificity in AOB-related biotransformation
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Sulfonamide antibiotics
No inhibition Inhibited by ATU
(~ 15 %)


















IATU (IOCT)  
Reference 
in this studyb 
Ibuprofen 10 1 100 100 0.25 0.03 (0)  (Tran et al., 2009) 
Ibuprofen 10 1e 70/140 2000 0 0.03 (0) (Roh et al., 2009) 
Ibuprofen 12 1.8-5.1 <2/10/29 100 0-0.47 0.03 (0) (Falas et al., 2012) 
Atenololc 30 1.73 20 15 0.63 0.04 (0.06) (Sathyamoorthy et al., 2013)
Bezafibrate 50 4-16 20 1 0.48 0.26 (0.29) (Maeng et al., 2013) 
Ketoprofen 5 NA 0-0.5 2 0.76 0.41 (0.28) (Rattier et al., 2014) 
Ketoprofen 10 1 100 100 0.57 0.41 (0.28) (Tran et al., 2009) 
Ketoprofen 50 4-16 20 1 0.75 0.41 (0.28) (Maeng et al., 2013) 
Diclofenacd 10 1 100 100 0.67 0.97 (0.58) (Tran et al., 2009) 
Diclofenac 50 4-16 20 1 0.32 0.97 (0.58) (Maeng et al., 2013) 
Furosemide 5 NA 0-0.5 2 0.78 0.79 (0.33) (Rattier et al., 2014) 
Indomethacin 10 1 100 100 0.86 0.74 (0.43) (Tran et al., 2009) 
Irgarol 11.1 2.5-4.7 50 1 0.37 0.36 (0.19) (Margot et al., 2016) 
Terbutryn 11.1 2.5-4.7 50 1 0.53 0.44 (0.14) (Margot et al., 2016) 
Trimethoprim 5 3.3 50 250 0.64 0.66 (0.60) (Batt et al., 2006) 
Trimethoprim 5 NA 0-0.5 2 <0 0.66 (0.60) (Rattier et al., 2014) 
Trimethoprim 10 NA ~24 0.5 0 0.66 (0.60) (Khunjar et al., 2011) 
(Men et al., Water Res.)
Insights into roles of AOB in MP biotransformation
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Microorganisms with enzymes 
not affected by ATU
Microorganisms with ATU-





























Parent compounds Transformation products
To test the hypothesis




Removal in full-scale WWTPs
Causal relationship between ammonia oxidizers and MP 
biotransformation
Roles of additional nitrification treatment (nitrification 




MP removal in each treatment step
Concluding Remarks
 AOB and AOA species were able to biotransform mianserin and ranitidine, 
likely via cometabolism by AMO.
 ATU is not a specific inhibitor to study the roles of ammonia oxidizers in 
NAS. Roles of AOB in MP biotransformation seem to be overestimated in 
inhibition studies using ATU. More specific inhibitors should be considered.
 AOB in NAS played a major role in the biotransformation of four 
compounds (i.e. asulam, clomazone, monuron, and trimethoprim). 
 Other microbes with ATU-affected enzymes were strongly involved in the 
biotransformation of a number of MPs, including thioethers and 
phenylureas.
 AOB and microorganisms with ATU-affected enzymes were not involved in 
the biotransformation of esters, chloroacetanilides and sulfonamide 
antibiotics (except for sulfathiazole) investigated in this study.
 MP biotransformation was carried out by multiple community members in 
NAS. TP identification can further help differentiate roles of community 
members.
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